KATAMARYN Trademark

Trademark Overview


On Wednesday, December 20, 2023, a trademark application was filed for KATAMARYN with the United States Patent and Trademark Office. The USPTO has given the KATAMARYN trademark a serial number of 98323695. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, April 8, 2025. This trademark is owned by Boston Pharmaceuticals, Inc.. The KATAMARYN trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the pharmaceutical and biotechnology fields; pharmaceutical drug development services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials
katamaryn

General Information


Serial Number98323695
Word MarkKATAMARYN
Filing DateWednesday, December 20, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, April 8, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 11, 2025

Trademark Statements


Description of MarkThe mark consists of the word "KATAMARYN" with a stylized tree in place of the "Y" and a swish mark beneath the "MARYN" letters of the word.
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesResearch and development in the pharmaceutical and biotechnology fields; pharmaceutical drug development services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, December 20, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBoston Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Party NameBoston Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events


Event DateEvent Description
Wednesday, December 20, 2023NEW APPLICATION ENTERED
Saturday, April 13, 2024NOTICE OF DESIGN SEARCH CODE E-MAILED
Saturday, April 13, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 23, 2024ASSIGNED TO EXAMINER
Friday, May 24, 2024LETTER OF SUSPENSION E-MAILED
Friday, May 24, 2024SUSPENSION LETTER WRITTEN
Friday, May 24, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, January 17, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 17, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 17, 2025ASSIGNED TO LIE
Wednesday, February 5, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, December 23, 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Sunday, January 19, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 11, 2025PUBLISHED FOR OPPOSITION
Tuesday, February 11, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 8, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT